REFRACTORY AML
Clinical trials for REFRACTORY AML explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY AML trials appear
Sign up with your email to follow new studies for REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy trial targets Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them b…
Matched conditions: REFRACTORY AML
Phase: PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …
Matched conditions: REFRACTORY AML
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC